DrugFeb 18, 2026
Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle recall — FDA D-0306-2026
Tablets/Capsules Imprinted with Wrong ID
Class IIIFDA: OngoingUnichem Pharmaceuticals USA Inc.
Recall history in this database
Classification mix: Class III: 5, Class II: 4, Class I: 1.
DrugFeb 11, 2026
Bisoprolol Fumarate and Hydrochlorothiazide tablets, USP, 2.5 mg/6.25 mg, 100-count bottle recall — FDA D-0301-2026
cGMP Deviations: recall due to not meeting the N-Nitroso Bisoprolol impurity specification limits.
Class IIFDA: OngoingUnichem Pharmaceuticals USA Inc.
DrugSep 24, 2025
Cyclobenzaprine Hydrochloride Tablets, USP, 10 mg, 90-count bottle recall — FDA D-0655-2025
Labeling: Label Mix Up; Bottles of Meloxicam USP, 7.5mg, 90-count tablets (yellow in color), were labeled as Cyclobenzaprine Hydrochloride Tablets USP, 10 mg 90-count tablets (blue in…
Class IFDA: OngoingUnichem Pharmaceuticals USA Inc.
DrugSep 28, 2022
Clonidine Hydrochloride Tablets, USP, 0.3 mg, 100-count bottle recall — FDA D-1541-2022
Product mix-up:0.2 mg strength Clonidine Hydrochloride Tablets, USP in a 100-count bottle of 0.3 mg strength Clonidine Hydrochloride Tablets,
Class IIIFDA: TerminatedUNICHEM PHARMACEUTICALS USA Inc.
DrugJun 17, 2020
Clonidine Hydrochloride Tablets, USP 0.1 mg 100-count bottles recall — FDA D-1291-2020
Failed Impurities/Degradation Specifications: potential migration of benzophenone at very low level into the product from container.
Class IIIFDA: TerminatedUNICHEM PHARMACEUTICALS USA Inc.
DrugFeb 12, 2020
Clonidine Hydrochloride Tablets, USP 0.1mg recall — FDA D-0829-2020
Failed Impurities/Degredation Specifications: This recall is initiated as a precautionary measure due to potential migration of Benzophenone at very low level into product from container…
Class IIIFDA: TerminatedUNICHEM PHARMACEUTICALS USA Inc.
DrugJan 24, 2018
Divalproex Sodium Delayed Release Tablets USP, 500 mg, 100-count bottle recall — FDA D-0228-2018
Cross Contamination With Other Products: metronidazole powder was found in one bottle of Divalproex Sodium.
Class IIFDA: TerminatedUnichem Pharmaceuticals Usa Inc.
DrugOct 25, 2017
Bisoprolol Fumarate tablets, 5 mg, 30-count bottles recall — FDA D-0010-2018
Failed Impurities/Degradation Specifications: Out of Specification for an unknown impurity was observed during the 18 month stability testing.
Class IIFDA: TerminatedUnichem Pharmaceuticals Usa Inc.
DrugOct 5, 2016
Lamotrigine Tablets, USP, 150 mg, 500-count Tablets per bottle recall — FDA D-1519-2016
Tablets/Capsules Imprinted With Wrong ID: incorrect imprint debossed on the tablets.
Class IIIFDA: TerminatedUnichem Pharmaceuticals Usa Inc.
DrugSep 2, 2015
Hydrochlorothiazide Tablet USP 25 mg,1000- count bottle recall — FDA D-1352-2015
Presence of Foreign Tablet: A pharmacist found a clopidogrel tablet in the 1000-count bottle of hydrochlorothiazide 25 mg tablets.
Class IIFDA: TerminatedUnichem Pharmaceuticals Usa Inc.
Understanding this recall history
This page summarizes recall records in which the official source identifies Unichem Pharmaceuticals Usa Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.